OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
Aimin Li, Qun Yan, Xinmei Zhao, et al.
Oncotarget (2015) Vol. 7, Iss. 1, pp. 524-537
Open Access | Times Cited: 23

Showing 23 citing articles:

Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
Yonger Chen, Jian Liang, Shuxian Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21

circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
Yiran Liang, Xiaojin Song, Yaming Li, et al.
Oncogene (2019) Vol. 38, Iss. 42, pp. 6850-6866
Closed Access | Times Cited: 126

CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 94

Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer
Lijuan Lyu, Shizhen Zhang, Yujiao Deng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 44

Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling
Shengbo Chen, Hongbin Liu, Zhijun Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 39

Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway
Shuang Wang, Yan He, Jun Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116566-116566
Open Access | Times Cited: 5

Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19

Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer
Debina Sarkar, Sarah D. Diermeier
Non-Coding RNA (2021) Vol. 7, Iss. 1, pp. 2-2
Open Access | Times Cited: 23

Landscape of NcRNAs involved in drug resistance of breast cancer
Yujuan Kang
Clinical & Translational Oncology (2023) Vol. 25, Iss. 7, pp. 1869-1892
Open Access | Times Cited: 9

PBLD promotes IRF3 mediated the type I interferon (IFN-I) response and apoptosis to inhibit viral replication
Hongchao Zhu, Peili Hou, Fengyun Chu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2

Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity
Simonetta Caira, Antonio Iannelli, Rosaria Sciarrillo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2017) Vol. 32, Iss. 1, pp. 672-682
Open Access | Times Cited: 19

Breast Cancer: Circular RNAs Mediating Efficacy in PreclinicalIn VivoModels
Ulrich H. Weidle, Hung‐En Hsia, Ulrich Brinkmann
Cancer Genomics & Proteomics (2023) Vol. 20, Iss. 3, pp. 222-238
Open Access | Times Cited: 6

PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles’ heel?
Laetitia Gérossier, A. Dubois, Alexia Paturel, et al.
Clinics and Research in Hepatology and Gastroenterology (2020) Vol. 45, Iss. 5, pp. 101553-101553
Open Access | Times Cited: 13

Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
Dai Shimizu, Yoshikuni Inokawa, Fuminori Sonohara, et al.
Oncology Reports (2017) Vol. 37, Iss. 5, pp. 2527-2542
Open Access | Times Cited: 12

PBLD enhances antiviral innate immunity by promoting the p53–USP4–MAVS signaling axis
Fengyun Chu, Peili Hou, Hongchao Zhu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 49
Closed Access | Times Cited: 1

Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients
Haiyun Yang, Ming Xu, Xiufang Chi, et al.
Clinics and Research in Hepatology and Gastroenterology (2017) Vol. 41, Iss. 5, pp. 554-563
Closed Access | Times Cited: 9

Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1
Jiansong Wu, Qiang Niu, Jie Yuan, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 9

LINC00858 promotes retinoblastoma cell proliferation, migration and invasion by inhibiting miR‑3182
Qi Wang, Yanni Zhu, Guojin Zuo, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 8

Proteomic Analysis of Hepatocellular Carcinoma Tissues With Encapsulation Shows Up-regulation of Leucine Aminopeptidase 3 and Phosphoenolpyruvate Carboxykinase 2
Keisuke Kuhara, Takao Kitagawa, Byron Baron, et al.
Cancer Genomics & Proteomics (2021) Vol. 18, Iss. 3, pp. 307-316
Open Access | Times Cited: 7

Walsura robusta Roxb. (Meliaceae), a little-known tree with a rich limonoid profile
Christian Bailly
Journal of Medicinal Herbs and Ethnomedicine (2021), pp. 11-17
Open Access | Times Cited: 1

Page 1

Scroll to top